Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Reportlinker Adds Pharmaceutical Management of Obesity (Technical Insights)

May 19, 2011 1:45 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 19, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Pharmaceutical Management of Obesity (Technical Insights)...

Takeda to Acquire Nycomed

May 18, 2011 11:37 pm | by Bio-Medicine.Org | News | Comments

OSAKA, Japan, and ZURICH, May 19, 2011 /- Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) and Nycomed A/S ("Nycomed") jointly announced today that Takeda has reached an agreement with the shareholders of Nycomed in which Takeda will acquire the Zurich-headquartered company for...

Images of a Hard-Hitting Disease

May 18, 2011 8:41 pm | by Massachusetts Institute of Technology | News | Comments

Advanced imaging techniques could help diagnose the degenerative brain disease linked to repetitive head trauma.

Advertisement

Internal Fixation Systems, Inc. Announces Form S-1 Declared Effective by SEC and Anticipated Quotation for Trading on OTCQB

May 18, 2011 11:51 am | by Bio-Medicine.Org | News | Comments

SOUTH MIAMI, Fla., May 18, 2011 /- Internal Fixation Systems, Inc (IFS)announced today that its Registration Statement on Form S-1 (SEC File No.  333-170008) was declared effective by the Securities and Exchange Commission ("SEC") on May 15, 2011.  In addition and...

Increased Demand for Visual Healthcare ADE Prevention Platform

May 18, 2011 11:49 am | by Bio-Medicine.Org | News | Comments

RENO, Nev., May 18, 2011 /- Visual Healthcare Corp. (the "Company") (NASDAQ OTC: VSHC) announces its decision to start selling a stand alone version of its powerful adverse drug event prevention technology to medical facilities and hospitals. The company is rolling out this new focused...

OTC Industry Supports FDA Advisory Committee Recommendations on New Dosing Instructions

May 18, 2011 11:49 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, May 18, 2011 /PRNewswire-USNewswire/ -- The Consumer Healthcare Products Association (CHPA), representing makers of over-the-counter (OTC) single-ingredient acetaminophen medicines for children, applauds the U.S. Food and Drug Administration (FDA) efforts to help parents and...

Neuro Kinetics Releases Updated Version of Neuro-Otologic Control and Analysis Software

May 18, 2011 11:47 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, May 18, 2011 /- Neuro Kinetics, Inc. (NKI) ( www.neuro-kinetics.com ), manufacturers of noninvasive medical diagnostic equipment used worldwide for neuro-physiologic, neuro-otologic, vestibular and neurological testing, said today that it has released version 6.10 of its...

Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay

May 18, 2011 11:46 am | by Bio-Medicine.Org | News | Comments

BERLIN, May 18, 2011 /- Research presented this week at the International Federation of Clinical Chemistry Congress and Laboratory Medicine showed that using a lower diagnostic threshold for troponin improves clinical outcomes and patient survival in patients with suspected acute coronary...

Advertisement

Tepha pulls in $5M funding for absorbable medical devices

May 18, 2011 9:55 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Lexington-based absorbable medical devices firm Tepha Inc. has raised $4.97 million of a planned $5.15 million equity financing, the company reported in a regulatory document.

Pearl Therapeutics' Phase 2b Results Show a 50% Improvement in Lung Function with PT003 Compared to Spiriva® and Foradil® in Patients with COPD

May 18, 2011 9:41 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., May 18, 2011 /- Pearl Therapeutics Inc. presented detailed efficacy and safety results today from the Company's phase 2b study of PT003  (GFF MDI) in patients with moderate-to-very severe COPD during a late-breaker poster session at the annual meeting of the...

ARX-01 and ARX-03 Clinical Results Presented at the 30th Annual Scientific Meeting of the American Pain Society

May 18, 2011 9:41 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., May 18, 2011 /- AcelRx Pharmaceuticals, Inc. announced today that the results from its Phase 2 clinical studies related to two product candidates, ARX-01 Sufentanil NanoTab(R) PCA System, which is designed to solve the problems associated with post-operative...

OBGYN Practices Refuse Obese Patients. Should You?

May 18, 2011 9:40 am | by Diagnostic Imaging | News | Comments

Some obstetricians are turning away obese patient, wary of the higher risk of complications and about the safety of patients on their exam tables. Radiology struggles with similar issues. Is it time to set limits?

Cancer Drug Use and Spending to Rise Sharply by 2013

May 18, 2011 9:40 am | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla., May 18, 2011 /- Expensive new cancer drugs treating increasing numbers of patients could drive cancer drug spending by as much as 15 percent a year through 2013. At this accelerated rate, oncology drugs will likely rise to the second or third largest trend-driving category...

Advertisement

CDRH OSEL Recruitment for ORISE: Post-doctoral researcher in Polymer Chemistry

May 18, 2011 9:33 am | by U.S. Food & Drug Administration | News | Comments

The candidate would be part of a collaborative team in the Division of Chemistry and Materials Science (DCMS), in the Office of Science and Engineering Labs (OSEL), at the Center for Devices and Radiological Health (CDRH) at FDA

IBM Helps Entrepreneurs Empower Patients With Tools To Improve Personal Health

May 18, 2011 8:38 am | by IBM | News | Comments

IBM (NYSE: IBM) is working closely with a group of entrepreneurs whose new technologies can transform how people manage their personal health, the company said today at its SmartCamp in Austin, Texas. The forum there, one of several the company will do this year, is part of its investment...

Ever Play 20 Questions with a Referring Physician?

May 18, 2011 8:38 am | by Diagnostic Imaging | News | Comments

At least one radiologist is tired of ED physicians asking 20 questions after every scan. Do you share his pain?

Celldex prices $31.5M stock offering

May 18, 2011 6:42 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Celldex Therapeutics Inc., the Needham company developing a brain cancer vaccine, has priced a public offering of 10 million shares of its common stock at about $3.15 per share. The offering would raise $31.5 million, with Celldex taking in about $29.4 million in net proceeds.

FluoroPharma Announces Completion of Merger and Fund Raising

May 18, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

BOSTON, May 18, 2011 /- FluoroPharma Medical (OTC.BB: CEWM) announced that it has completed a merger transaction with Commercial E Waste Management (CEWM). Effective as of the closing of the transaction, FluoroPharma became a wholly-owned subsidiary of CEWM. The newly combined, publicly...

PLC Medical Systems Adds Vice President of Clinical Affairs

May 18, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Mass., May 18, 2011 /- PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced that it has named Susan Papalia, RN, BSN, Vice President of Clinical Affairs.  In her new role, she will be responsible for overseeing and...

Draft Guidance for Industry and Food and Drug Administration Staff - Class II Special Controls Guidance Document: In Vitro Diagnostic Devices for Bacillus spp. Detection

May 18, 2011 6:31 am | by U.S. Food & Drug Administration | News | Comments

This draft special controls guidance document was developed to support the proposed classification of in vitro diagnostic device for Bacillus spp. detection, a previously unclassified type of preamendments device, into class II, as recommended by the...

Cepheid Appoints LABSCO as US Small Hospital Distributor

May 18, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., May 18, 2011 /- Cepheid (NASDAQ: CPHD ) today announced it has entered into an agreement with LABSCO ( www.labsco.com ), the largest privately held distributor of clinical products in the United States, to become its US distribution partner for Cepheid's GeneXpert®...

Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN® Device

May 18, 2011 4:33 am | by Boston Scientific | News | Comments

Results for Boston Scientific WATCHMAN device presented at EuroPCR

Reportlinker Adds Hong Kong SMBG Devices and Strips Market

May 18, 2011 1:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 18, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Hong Kong SMBG Devices and Strips Market...

Shire buys Advanced BioHealing for $750M

May 17, 2011 2:35 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

Advanced BioHealing Inc., the Connecticut biotech that filed for a $200 million IPO at the beginning of May, has been scooped up before its IPO for $750 million cash by Shire plc, the Irish company with its Human Genetic Therapies business presence in Lexington.

University Hospitals Seidman Cancer Center Announces $30 Million Proton Therapy Center

May 17, 2011 12:38 pm | by Bio-Medicine.Org | News | Comments

CLEVELAND, May 17, 2011 /- University Hospitals Seidman Cancer Center announced plans to establish a $30 million proton therapy center, becoming one of an elite group of cancer centers in the country to offer this revolutionary technology. Proton therapy is an advanced type of radiation...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading